SHR-A2102: Clinical Trials

1 trial of SHR-A2102, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1
Phase 31Recruiting 1

Follow SHR-A2102: new trials by email Literature Review of SHR-A2102 trials Research Report on SHR-A2102

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With Adebrelimab (SHR-1316)
SHR-A2102, Adebrelimab, Gemcitabine Hydrochloride for Injection - Muscular Invasive Bladder Cancer (MIBC)
Phase 2 / Phase 3RecruitingSuzhou Suncadia Biopharmaceuticals Co., Ltd.7402025-04-252026-11-12

Sponsors

Suzhou Suncadia Biopharmaceuticals Co., Ltd. (1)

Countries

China (1)